Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage

Br J Pharmacol. 1999 Jun;127(3):685-92. doi: 10.1038/sj.bjp.0702604.

Abstract

1. The relative contributions of superoxide anion (O2-) and peroxynitrite (PN) were evaluated in the pathogenesis of intestinal microvascular damage caused by the intravenous injection of E. coli lipopolysaccharide (LPS) in rats. The superoxide dismutase mimetic (SODm) SC-55858 and the active peroxynitrite decomposition catalysts 5,10,15,20-tetrakis(2,4,6-trimethyl-3,5-disulphonatophenyl)-por phyrinato iron (III) and 5,10,15,20-tetrakis(N-methyl-4'-pyridyl)-porphyrinato iron (III) (FeTMPS, FeTMPyP respectively) were used to assess the roles of O2- and PN respectively. 2. The intravenous injection of LPS elicited an inflammatory response that was characterized by a time-dependent infiltration of neutrophils, lipid peroxidation, microvascular leakage (indicative of microvascular damage), and epithelial cell injury in both the duodenum and jejunum. 3. Administration of the SODm SC-55858, FeTMPS or FeTMPyP at 3 h post LPS reduced the subsequent increase in microvascular leakage, lipid peroxidation and epithelial cell injury. Inactive peroxynitrite decomposition catalysts exhibited no protective effects. Only, SC-55858 inhibited neutrophil infiltration. 4. Our results suggest that O2 and peroxynitrite play a significant role in the pathogenesis of duodenal and intestinal injury during endotoxaemia and that their remoyal by SODm and peroxynitrite decomposition catalysts offers a novel approach to the treatment of septic shock or clinical conditions of gastrointestinal inflammation. Furthermore, the remarkable protection of the intestinal epithelium by these agents suggests their use during chemo- and radiation therapy, cancer treatments characterized by gastrointestinal damage. Potential mechanisms through which these radicals evoke damage are discussed.

MeSH terms

  • Animals
  • Catalysis
  • Colchicine / pharmacology
  • Ferric Compounds / pharmacology
  • Free Radical Scavengers / metabolism
  • Free Radical Scavengers / pharmacology*
  • Intestinal Mucosa / blood supply
  • Intestinal Mucosa / enzymology*
  • Intestinal Mucosa / metabolism
  • Intestinal Mucosa / pathology*
  • Lipid Peroxidation / drug effects
  • Lipopolysaccharides / toxicity*
  • Male
  • Metalloporphyrins / pharmacology
  • Neutrophils / drug effects
  • Neutrophils / metabolism
  • Neutrophils / pathology
  • Nitrates / metabolism
  • Nitrates / toxicity*
  • Organometallic Compounds / metabolism
  • Organometallic Compounds / pharmacology*
  • Oxidants / metabolism
  • Oxidants / toxicity*
  • Porphyrins / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Superoxide Dismutase / metabolism
  • Superoxide Dismutase / pharmacology*
  • Superoxides / metabolism

Substances

  • 5,10,15,20-tetrakis(2,4,6-trimethyl-3,3-disulfonatophenyl)porphyrinato iron(III)
  • Ferric Compounds
  • Free Radical Scavengers
  • Lipopolysaccharides
  • Metalloporphyrins
  • Nitrates
  • Organometallic Compounds
  • Oxidants
  • Porphyrins
  • meso-tetrakis(1-methyl-4-pyridiniumyl)porphyrin
  • Superoxides
  • SC 55858
  • peroxynitric acid
  • Superoxide Dismutase
  • Colchicine